Michel Bouchoucha1,2, Ghislain Devroede3, Florence Mary4, Cyriaque Bon4, Bakhtiar Bejou4, Robert Benamouzig4. 1. Université Paris V René Descartes, 15, rue de l'école de médecine, 75270, Paris Cedex 06, France. michel.bouchoucha@avc.aphp.fr. 2. CEFRED (centre d'exploration fonctionnelle et de rééducation digestive), Service de Gastroentérologie, Hôpital Avicenne, 125, rue de Stalingrad, 93009, Bobigny Cedex, France. michel.bouchoucha@avc.aphp.fr. 3. Département de Chirurgie, Faculté de Médecine, Université de Sherbrooke, Sherbrooke, QC, Canada. 4. CEFRED (centre d'exploration fonctionnelle et de rééducation digestive), Service de Gastroentérologie, Hôpital Avicenne, 125, rue de Stalingrad, 93009, Bobigny Cedex, France.
Abstract
PURPOSE: Abdominal pain is not used to characterize constipated patients. This study aimed to compare clinical, psychological, and physiological features in patients with IBS-constipation (IBS-C) with those in patients with functional constipation (FC) according to the intensity of abdominal pain. METHODS: All patients filled a standard Rome III questionnaire. In addition, they indicated the intensity of constipation, diarrhea, bloating, and abdominal pain on a 10-point Likert scale, and their stool form with the Bristol Stool Form Scale. Anxiety and depression were assessed with the Beck Depression Inventory and the State-Trait Anxiety Inventory. Physiological evaluation included anorectal manometry and total and segmental colonic transit time. MAIN RESULTS: A total of 546 consecutive patients, 245 with IBS-C and 301 with FC, were included. Painful constipation (PFC) was found by cluster analysis and subsequently defined as having a value over four on the Likert scale for abdominal pain. PFC was found in 67% of IBS-C patients and in 22% of FC patients. PFC patients have digestive disorders with greater frequency and report higher levels of constipation and bloating, despite similar stool form. They have higher scores of depression, state and trait anxiety, and shorter terminal transit time than mild-pain constipated patients. Compared to IBS-C patients, PFC patients report higher levels of abdominal pain (P < 0.001). Psychological and physiological parameters were similar in PFC and IBS-C patients. CONCLUSION: Painful constipation and mild-pain constipation could be an alternative way to identify constipated patients than using the diagnosis of IBS-C and FC for clinical evaluation and drug studies.
PURPOSE:Abdominal pain is not used to characterize constipatedpatients. This study aimed to compare clinical, psychological, and physiological features in patients with IBS-constipation (IBS-C) with those in patients with functional constipation (FC) according to the intensity of abdominal pain. METHODS: All patients filled a standard Rome III questionnaire. In addition, they indicated the intensity of constipation, diarrhea, bloating, and abdominal pain on a 10-point Likert scale, and their stool form with the Bristol Stool Form Scale. Anxiety and depression were assessed with the Beck Depression Inventory and the State-Trait Anxiety Inventory. Physiological evaluation included anorectal manometry and total and segmental colonic transit time. MAIN RESULTS: A total of 546 consecutive patients, 245 with IBS-C and 301 with FC, were included. Painful constipation (PFC) was found by cluster analysis and subsequently defined as having a value over four on the Likert scale for abdominal pain. PFC was found in 67% of IBS-Cpatients and in 22% of FC patients. PFC patients have digestive disorders with greater frequency and report higher levels of constipation and bloating, despite similar stool form. They have higher scores of depression, state and trait anxiety, and shorter terminal transit time than mild-pain constipatedpatients. Compared to IBS-Cpatients, PFC patients report higher levels of abdominal pain (P < 0.001). Psychological and physiological parameters were similar in PFC and IBS-Cpatients. CONCLUSION:Painful constipation and mild-pain constipation could be an alternative way to identify constipatedpatients than using the diagnosis of IBS-C and FC for clinical evaluation and drug studies.
Authors: S S C Rao; M Camilleri; W L Hasler; A H Maurer; H P Parkman; R Saad; M S Scott; M Simren; E Soffer; L Szarka Journal: Neurogastroenterol Motil Date: 2011-01 Impact factor: 3.598
Authors: M Bouchoucha; M Fysekidis; G Devroede; J-J Raynaud; B Bejou; R Benamouzig Journal: Neurogastroenterol Motil Date: 2013-05-27 Impact factor: 3.598
Authors: W E Whitehead; M D Crowell; L Bosmajian; A Zonderman; P T Costa; C Benjamin; J C Robinson; B R Heller; M M Schuster Journal: Gastroenterology Date: 1990-02 Impact factor: 22.682
Authors: Adil E Bharucha; G Richard Locke; Alan R Zinsmeister; Barbara M Seide; Kimberly McKeon; Cathy D Schleck; L Joseph Melton Journal: Am J Gastroenterol Date: 2006-02-08 Impact factor: 10.864
Authors: Z Mujagic; D Keszthelyi; Q Aziz; W Reinisch; E G Quetglas; F De Leonardis; M Segerdahl; A A M Masclee Journal: Aliment Pharmacol Ther Date: 2015-08-20 Impact factor: 8.171